跳到正文
研踪PaperTrail

论文库

检索计算机领域论文,按研究方向、作者或关键词筛选。

部分采集异常
正在读取账号与研究记录…

全站更新概况

+479新增论文
+361其中 AI 相关
+63已有论文修订
+93新增 AI 导读

arXiv 最近完成扫描:2026-11-16 01:34 · 全站最近入库:2026-11-16 13:44各信源进度 →

统计口径与数据新鲜度

统计 2026-11-15 14:16 — 2026-11-16 14:16(北京时间) · 点击数字查看对应简报;AI 相关包含在新增论文内。

最近完成检查:2026-11-16 01:34最近发现新增版本:2026-11-16 13:44库内论文最新更新时间:2026-11-14 02:59

每分钟刷新已保存的数据。空检查不代表采集异常;新收录可能包含历史论文。AI 导读按新增版本计数。

23,827 已收录论文19,941 AI 相关6,921 有修订112 HF 社区发现

浏览论文库

时间范围跟随排序:版本更新、本站收录或首次发表。最新收录可能包含历史论文。部分信源异常,查看状态 →

找到 1 篇论文 · 按版本更新时间排序上轮扫描起点 2026-11-16 01:33(北京时间)
版本更新 · v2arXiv:2606.05373

Evidence-Guided Neural Architecture Selection under Uncertainty for Subject-Specific Blood Glucose Forecasting

Md Azharul Islam, Dwyer Deighan, Tarunraj Singha, Danial Faghihi

原文摘要

Reliable neural architecture selection is an open challenge in time-series forecasting under limited, noisy, and heterogeneous data, where standard heuristic architecture design and validation approaches fail to ensure accurate and reliable prediction and generalization. We propose EVIDENT (EVidence-based IDEntification of Neural archiTectures), a framework for architecture selection that integrates Bayesian training, evidence-based ranking, and task-specific validation under uncertainty. The framework explores the candidate architecture pool and identifies the lowest-capacity model that satisfies a prescribed validation criterion. We demonstrate this method using temporal convolutional networks (TCNs) for individualized blood glucose forecasting in type 1 diabetes patients. The results show that EVIDENT systematically rejects both under- and over-parameterized TCN architectures on population-level diabetes data, while identifying models that generalize reliably to unseen patients. When multiple architectures are competitive, the framework further supports plausibility-weighted ensemble predictions that enhance predictive performance. Compared with a random-search baseline, EVIDENT identified smaller architectures with more consistent forecasting performance on unseen patients. These findings establish EVIDENT as a strategy to neural architecture discovery, enabling reliable model selection for high-consequence forecasting in data-limited and heterogeneous settings.

cs.LG · physics.bio-ph